Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

75%(3 trials)

Phase Distribution

Ph phase_2

20%

Ph early_phase_1

20%

Ph not_applicable

40%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (20.0%)

Phase 11 (20.0%)

Phase 21 (20.0%)

N/A2 (40.0%)

Trials by Status

completed480%

withdrawn120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

NCT02002533

completedphase_1

Brief Interventions for Drop-out Re-engagement

NCT00350571

Clinical Trials (5)

Showing 5 of 5 trials

NCT05417412Not Applicable

Video-visit Behavior Therapy for Anxiety and Depression in Youth

Completed

NCT04317300Early Phase 1

Feasibility of Treatment for Vaping Cessation

Withdrawn

NCT03339583Phase 2

Effectiveness of BBT-I and Zopiclone for Chronic Insomnia

Completed

NCT02002533Not Applicable

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Completed

NCT00350571Phase 1

Brief Interventions for Drop-out Re-engagement

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5